Literature DB >> 12884913

P21-activated kinases in human cancer.

Ratna K Vadlamudi1, Rakesh Kumar.   

Abstract

A balance between proliferation, differentiation, migration and death of cells is critical for the normal development of an organism. Perturbations of this balance can contribute to cancer development. The p21-activated serine/threonine kinases (Paks) play an important role in a variety of cellular functions including cell morphogenesis, motility, survival, angiogenesis, and mitosis. Paks were initially identified as an effector molecules of RHO GTPases; however, recent evidence that they can be activated in both GTPase-dependent and -independent manners expands our understanding of their physiologic functions. Paks play an important role in growth factor signaling, leading to cytoskeletal reorganization that subsequently influences growth factor-mediated cell migration and metastasis functions. Recent findings that Paks play a role in mitosis, nuclear receptor-signaling and deregulation of Pak in cancer cells suggest that these kinases play an important role in both normal development and cancer progression. In this review, we summarize the results of recent advances into the role of Paks in tumorigenesis and metastasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884913     DOI: 10.1023/a:1023729130497

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  31 in total

1.  The transforming Rho family GTPase Wrch-1 disrupts epithelial cell tight junctions and epithelial morphogenesis.

Authors:  Donita C Brady; Jamie K Alan; James P Madigan; Alan S Fanning; Adrienne D Cox
Journal:  Mol Cell Biol       Date:  2008-12-08       Impact factor: 4.272

2.  An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently.

Authors:  Julien Viaud; Jeffrey R Peterson
Journal:  Mol Cancer Ther       Date:  2009-09-01       Impact factor: 6.261

3.  Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility.

Authors:  Leah Rider; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2011-05-12

Review 4.  Structure, biochemistry, and biology of PAK kinases.

Authors:  Rakesh Kumar; Rahul Sanawar; Xiaodong Li; Feng Li
Journal:  Gene       Date:  2016-12-19       Impact factor: 3.688

5.  p21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor.

Authors:  Beatriz Sánchez-Solana; Mona Motwani; Da-Qiang Li; Jeyanthy Eswaran; Rakesh Kumar
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

6.  Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.

Authors:  Melania Ester Mercado-Pimentel; Craig Miller; Daniela N Rolph; Edrick F Villalobos; Allison M Dunn; Prithvi M Mohan; Suzu Igarashi; Xiangdang Liu; Macken Yrun-Duffy; Neal K Patel; Cecilia M Read; Ross H Francis; Adelina Isabella Lane; Swaroop Murugesh; Abraham Jacob
Journal:  Otol Neurotol       Date:  2017-01       Impact factor: 2.311

7.  Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A.

Authors:  Poonam R Molli; Da-Qiang Li; Rozita Bagheri-Yarmand; Suresh B Pakala; Hiroshi Katayama; Subrata Sen; Jyoti Iyer; Jonathan Chernoff; Ming-Ying Tsai; Sujit S Nair; Rakesh Kumar
Journal:  J Cell Biol       Date:  2010-07-05       Impact factor: 10.539

8.  PAK is regulated by PI3K, PIX, CDC42, and PP2Calpha and mediates focal adhesion turnover in the hyperosmotic stress-induced p38 pathway.

Authors:  Perry M Chan; Louis Lim; Edward Manser
Journal:  J Biol Chem       Date:  2008-06-27       Impact factor: 5.157

9.  Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration.

Authors:  Yihui Ma; Samantha K McCarty; Naval P Kapuriya; Victoria J Brendel; Chaojie Wang; Xiaoli Zhang; David Jarjoura; Motoyasu Saji; Ching-Shih Chen; Matthew D Ringel
Journal:  J Clin Endocrinol Metab       Date:  2013-05-24       Impact factor: 5.958

10.  Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire.

Authors:  I H Chan; M L Privalsky
Journal:  Oncogene       Date:  2009-09-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.